Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Selected Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2012

The following table contains quarterly financial information for fiscal years 2012 and 2011.


(in thousands, except per share data)	First Quarter			Second Quarter			Third Quarter			Fourth Quarter
2012
Operating expenses	$	(6,581	)	$	(6,465	)	$	(5,831	)	$	(8,299	)
Other income/(expense)	$	25		$	10		$	(104	)	$	(365	)
Net loss	$	(6,556	)	$	(6,455	)	$	(5,935	)	$	(8,664	)
Basic and diluted net loss per common share	$	(0.35	)	$	(0.34	)	$	(0.24	)	$	(0.36	)

2011
Operating expenses	$	(22,545	)	$	(3,736	)	$	(3,531	)	$	(5,232	)
Other income/(expense)	$	2		$	3		$	166		$	(1,487	)
Net loss	$	(22,543	)	$	(3,733	)	$	(3,365	)	$	(6,719	)
Basic and diluted net loss per common share	$	(4.71	)	$	(0.64	)	$	(0.48	)	$	(0.52	)